Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Other financing activities: 2009-2019

Historic Other financing activities for Northwest Biotherapeutics (NWBO) over the last 4 years, with Dec 2019 value amounting to $108,000.

  • Northwest Biotherapeutics' Other financing activities was N/A to $108,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $246,000, marking a year-over-year change of. This contributed to the annual value of $108,000 for FY2019, which is 21.74% down from last year.
  • Per Northwest Biotherapeutics' latest filing, its Other financing activities stood at $108,000 for Q4 2019, which was down 21.74% from $138,000 recorded in Q2 2018.
  • Northwest Biotherapeutics' 5-year Other financing activities high stood at $2.5 million for Q3 2017, and its period low was -$2.5 million during Q4 2017.
  • For the 3-year period, Northwest Biotherapeutics' Other financing activities averaged around $41,000, with its median value being $123,000 (2018).
  • Per our database at Business Quant, Northwest Biotherapeutics' Other financing activities surged by 13,700.00% in 2015 and then tumbled by 894.39% in 2017.
  • Northwest Biotherapeutics' Other financing activities (Quarterly) stood at $138,000 in 2015, then surged by 447.83% to $321,000 in 2016, then slumped by 894.39% to -$2.5 million in 2017, then skyrocketed by 119.91% to $138,000 in 2018, then reached $108,000 in 2019.
  • Its Other financing activities was $108,000 in Q4 2019, compared to $138,000 in Q2 2018 and -$2.5 million in Q4 2017.